Literature DB >> 16096020

Section I. The cholinergic system.

John Smythies.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16096020     DOI： 10.1016/S0074-7742(05)64001-9

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN： 0074-7742            Impact factor:   3.230


× No keyword cloud information.
  20 in total

1.  The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.

Authors:  Derek S Wilkinson; Thomas J Gould
Journal:  Behav Brain Res       Date:  2011-04-14       Impact factor: 3.332

2.  The mouse homeobox gene Gbx2 is required for the development of cholinergic interneurons in the striatum.

Authors:  Li Chen; Mallika Chatterjee; James Y H Li
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

Review 3.  Cholinergic functioning in stimulant addiction: implications for medications development.

Authors:  Mehmet Sofuoglu; Marc Mooney
Journal:  CNS Drugs       Date:  2009-11       Impact factor: 5.749

4.  Further optimization of the mGlu5 PAM clinical candidate VU0409551/JNJ-46778212: Progress and challenges towards a back-up compound.

Authors:  Ya Zhou; Chrysa Malosh; Susana Conde-Ceide; Carlos Manuel Martínez-Viturro; Jesus Alcázar; Hilde Lavreysen; Claire Mackie; Thomas M Bridges; J Scott Daniels; Colleen M Niswender; Carrie K Jones; Gregor J Macdonald; Thomas Steckler; P Jeffrey Conn; Shaun R Stauffer; José Manuel Bartolomé-Nebreda; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2015-07-04       Impact factor: 2.823

5.  Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease.

Authors:  Ditte Dencker; Morgane Thomsen; Gitta Wörtwein; Pia Weikop; Yinghong Cui; Jongrye Jeon; Jürgen Wess; Anders Fink-Jensen
Journal:  ACS Chem Neurosci       Date:  2012       Impact factor: 4.418

6.  Discovery of novel N-substituted oxindoles as selective m1 and m4 muscarinic acetylcholine receptors partial agonists.

Authors:  Takaaki Sumiyoshi; Takeshi Enomoto; Kentaro Takai; Yoko Takahashi; Yasuko Konishi; Yoshiharu Uruno; Kengo Tojo; Atsushi Suwa; Harumi Matsuda; Tomokazu Nakako; Mutsuko Sakai; Atsushi Kitamura; Yasuaki Uematsu; Akihiko Kiyoshi
Journal:  ACS Med Chem Lett       Date:  2013-01-27       Impact factor: 4.345

Review 7.  Cognitive function as an emerging treatment target for marijuana addiction.

Authors:  Mehmet Sofuoglu; Dawn E Sugarman; Kathleen M Carroll
Journal:  Exp Clin Psychopharmacol       Date:  2010-04       Impact factor: 3.157

Review 8.  Physiological roles of CNS muscarinic receptors gained from knockout mice.

Authors:  Morgane Thomsen; Gunnar Sørensen; Ditte Dencker
Journal:  Neuropharmacology       Date:  2017-09-11       Impact factor: 5.250

9.  Inhibition of acetylcholinesterase activity in brain and behavioral analysis in adult rats after chronic administration of fenproporex.

Authors:  Gislaine T Rezin; Giselli Scaini; Gabriela K Ferreira; Mariane R Cardoso; Cinara L Gonçalves; Larissa S Constantino; Pedro F Deroza; Fernando V Ghedim; Samira S Valvassori; Wilson R Resende; João Quevedo; Alexandra I Zugno; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2012-07-27       Impact factor: 3.584

10.  Combined scopolamine and ethanol treatment results in a locomotor stimulant response suggestive of synergism that is not blocked by dopamine receptor antagonists.

Authors:  Angela C Scibelli; Tamara J Phillips
Journal:  Alcohol Clin Exp Res       Date:  2008-12-13       Impact factor: 3.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.